IJ Pharmaceutical Research
Scopus by Title (Ref)
1. KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury
- Hou W. , et al.
2. Identification of Chemical Scaffolds Targeting Drug-Resistant and Latent Mycobacterium tuberculosis through High-Throughput Whole-Cell Screening
- Perveen S. , et al.
3. New Insights into Co-Administration of Anti-Tuberculosis Drug Rifampicin with Acetaminophen and Vitamin C: Strong Electrochemical Evidence for the Detoxification
- Zivari-Moshfegh F. , et al.
4. Preliminary Screening of Durio Zibethinus Linn (D197) Leaf Extracts for Its Antioxidant Activity and Cytotoxicity on Cervix Adenocarcinoma (HELA) Cancer Cell Line
- Lim W.Y. , et al.
6. In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis
- Marquês J.T. , et al.
7. Non-Clinical Investigation of Tuberculosis Drugs: Conjugated Nor-bornene-Based Nanocarriers Toxic Impacts on Zebrafish
- Anju T. , et al.
9. Amelioration of fenitrothion induced oxidative DNA damage and inactivation of caspase-3 in the brain and spleen tissues of male rats by N-acetylcysteine
- Alam R.T. , et al.
10. Studies on chemical constituents and bioactivities of leaves of Torreya grandis
- Duan F.F. , et al.
11. Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response
- Zhang W. , et al.
12. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains
- Khameneh B. , et al.